Roche's VENTANA FOLR1 RxDx Assay has received CE mark approval for identifying epithelial ovarian cancer patients suitable for AbbVie's ELAHERE therapy.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Roche's VENTANA FOLR1 RxDx Assay has received CE mark approval for identifying epithelial ovarian cancer patients suitable for AbbVie's ELAHERE therapy.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing